Work

The value of observational registry studies for the next infectious disease emergency

Year: 2023

Type: editorial

Abstract: During infectious disease emergencies, it may be necessary to deploy new therapies without conclusive evidence for their effectiveness. During the SARS-CoV-2 pandemic, several countries used registries to track the use of COVID-19 convalescent plasma (CCP). Those registries provided evidence that CCP was effective when used early and with high titer.

Source: mBio

DOI: 10.1128/mbio.02565-23

Authors: Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, Michael J. Joyner

Institutions: University of Illinois Urbana-Champaign, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Johns Hopkins University, Mayo Clinic

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,900

OpenAlex ID: W4388500452

Cites: 26

Cited by: 5

Related to: 10